Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD

@article{Hadi2018EfficacyOS,
  title={Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD},
  author={Amir Hadi and Hamed Mohammadi and Maryam Miraghajani and Ehsan Ghaedi},
  journal={Critical Reviews in Food Science and Nutrition},
  year={2018},
  volume={59},
  pages={2494 - 2505}
}
ABSTRACT Objective: We systematically reviewed available randomized clinical trials (RCTs) to elucidate the overall effects of synbiotic supplementation in patients with nonalcoholic fatty liver disease (NAFLD). Methods: PubMed, Scopus, ISI Web of science and Google Scholar were searched up to December, 2017. All RCTs using synbiotic supplements to treat NAFLD included in this systematic review and meta-analysis. Mean Difference (MD) was pooled using a random-effects model. Results: Eleven… 

Efficacy of synbiotic supplementation in obesity treatment: A systematic review and meta-analysis of clinical trials

Modulation of gut microbiota composition through synbiotic supplementation might have modest effects on body weight and waist circumference, according to the present meta-analysis of 23 randomized trials.

The effects of supplementation of probiotics, prebiotics, or synbiotics on patients with non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials

Background Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease. Research on the efficacy of probiotics, prebiotics, and synbiotics on NAFLD patients continues to be

Probiotics, prebiotics, and synbiotics for the improvement of metabolic profiles in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials

A meta-analysis supports the potential use of probiotic, prebiotic, and synbiotic supplements in the improvement of established biomarkers of inflammation and oxidative stress, as well as lipid profiles among patients with CKD, which are well-known cardiovascular risk factors.

Effects of synbiotic consumption on lipid profile: a systematic review and meta-analysis of randomized controlled clinical trials

Synbiotic supplements may be beneficial to improve lipid profile, especially when they are consumed for > 8 weeks, and the effects are more pronounced when synbiotics supplements are eaten for’s more pronounced.

Probiotic and prebiotic interventions for non-alcoholic fatty liver disease: a systematic review and network meta-analysis.

NMA results provide evidence that probiotics, prebiotics, and synbiotics can alleviate non-alcoholic fatty liver disease, however, due to the lack of high-quality randomised trials, this research also has some limitations.

PROBIOTIC, PREBIOTIC OR SYMBIOTIC SUPPLEMENTATION IMPACTS ON INTESTINAL MICROBIOTA IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE: A SYSTEMATIC REVIEW

Although there is a possible change in the gut microbiota of individuals with NAFLD after supplementation with symbiotics or prebiotics, a clinical indication as part of NA FLD treatment is not yet possible.

Synbiotic Alters Fecal Microbiomes, but not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Non-alcoholic Fatty Liver Disease.

In a randomized trial of patients with NAFLD, 1 y administration of a synbiotic combination (probiotic and prebiotic) altered fecal microbiomes but did not reduce liver fat content or markers of liver fibrosis.

Role of probiotics/synbiotic supplementation in glycemic control: A critical umbrella review of meta-analyses of randomized controlled trials.

Current umbrella meta-analysis strongly supporting the beneficial health effects of probiotics/synbiotic supplementation in glycemic control and subgroup analysis showed that patients with impaired glucose homeostasis might benefit the most from probiotic/syn biotic supplementation.

References

SHOWING 1-10 OF 49 REFERENCES

Effects of probiotics on nonalcoholic fatty liver disease: a meta-analysis.

AIM To investigate the relationship between the gut-liver axis and nonalcoholic fatty liver disease (NAFLD), we performed a meta-analysis to evaluate the effects of probiotic therapy in NAFLD.

Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study.

Synbiotic supplementation in addition to lifestyle modification is superior toifestyle modification alone for the treatment of NAFLD, at least partially through attenuation of inflammatory markers in the body.

Role of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-analysis

Meta-analysis shows that variety of parameters has significant improvement after probiotic treatment in different RCTs, however, the magnitude of improvement is not uniform across studies due to varying strains, dose patterns, and treatment duration.

The Effects of Synbiotic Supplementation on Glucose Metabolism and Lipid Profiles in Patients with Diabetes: a Systematic Review and Meta-Analysis of Randomized Controlled Trials

Synbiotic consumption significantly changed glucose metabolism, and may result in an improvement in FPG, insulin, HOMA-IR, HomA-B, QUICKI, triglycerides, and total cholesterol.

Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial

Evidence is provided that synbiotic supplementation improves the main features of NAFLD in patients with normal and low BMI, at least partially through reduction in inflammatory indices.

The Effect of Synbiotic Supplementation on Body Composition and Lipid Profile in Patients with NAFLD: A Randomized, Double Blind, Placebo-Controlled Clinical Trial Study

Synbiotic supplementation may improve lipid profile and body composition in patients with NAFLD and might be useful in prevention of the disease progression.

The Effect of Symbiotic Supplementation on Liver Enzymes, C-reactive Protein and Ultrasound Findings in Patients with Non-alcoholic Fatty Liver Disease: A Clinical Trial

Symbiotic supplementation improved steatosis in NAFLD patients and might be useful in the management ofNAFLD or protective against its progression.

Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis

It is concluded that synbiotic supplementation associated with nutritional counseling seems superior to nutritional counseling alone for NASH treatment as it attenuates steatosis and may help to achieve weight loss.

Do symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial

In this study, symbiotic plus Vitamin E supplementation was the most effective treatment in lowering liver enzymes, leptin, FBS, insulin, TG, TC, and LDL-C among NAFLD patients.

The Potential Role of Probiotics or / and Prebiotic on Serum Lipid Profile and Insulin Resistance in Alcoholic Fatty Liver Disease : A Double Blind Randomized Clinical Trial

Probiotic and prebiotic supplementation may be effective in improving serum lipid profile and insulin resistance markers in patients diagnosed with NAFLD.